Vaccines and immunization against human papillomavirus

Keyphrases

• Immunization 100%
• High-risk Human Papillomavirus (HR-HPV) 100%
• Immune Response 40%
• Papillomavirus Infections 40%
• Immunotherapeutics 40%
• Cancer-related 40%
• In Situ 20%
• Effective Method 20%
• Clinical Disease 20%
• Capsid Protein 20%
• Capsid 20%
• Virus-like 20%
• Viral Pathogens 20%
• Human Papillomavirus Types 20%
• Cross-protection 20%
• Next-generation Vaccines 20%
• Effector T Cells 20%
• Cellular Immunity 20%
• Continual Improvement 20%
• Innate Immunity 20%
• Immunogen 20%
• Immune Effectors 20%
• Adaptive Immunity 20%
• Complete Clearance 20%
• Associated Lesions 20%
• Infection Site 20%
• Early Protein 20%
• Broad Protection 20%
• Associated Diseases 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Human Papillomavirus 100%
• Malignant Neoplasm 83%
• Disease 33%
• Papillomavirus Infection 33%
• Infectious Agent 16%
• Infection 16%
• Capsid Protein 16%
• Antivirus Agent 16%
• Virus Like Agent 16%
• Adjuvant 16%
• Antigen 16%
• Papillomaviridae 16%

Immunology and Microbiology

• Vaccine Efficacy 100%
• Wart Virus 100%
• Capsid 25%
• Infectious Agent 12%
• T Cell 12%
• Adaptive Immune System 12%
• Innate Immune System 12%
• Immune Response 12%
• Virus-Like Particle 12%
• Papillomaviridae 12%
• Adoptive Immunity 12%
• Antigen 12%
• Adjuvant 12%
• Cross Protection 12%